Drug-drug interaction between tamsulosin and diltiazem, a moderate CYP3A4 inhibitor

被引：0
|
作者：
Byeon, Ji-Yeong [1 ]
Park, Jung-In [1 ]
Jang, Choon-Gon [1 ]
Lee, Seok-Yong [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea
来源：
PHARMACOTHERAPY | 2012年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E238 / E239
页数：2
相关论文
共 50 条
  • [1] EFFECT OF DILTIAZEM, A MODERATE CYP3A4 INHIBITOR, ON THE PHARMACOKINETIC PARAMETERS OF TAMSULOSIN
    Lee, Y.
    Byeon, J. Y.
    Kim, Y. H.
    Kim, S. H.
    Lee, H. J.
    Lee, Y. J.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E61 - E62
  • [2] Physiologically Based Pharmacokinetic Modeling of the Drug-Drug Interaction Between CYP3A4 Substrate Glasdegib and Moderate CYP3A4 Inducers in Lieu of a Clinical Study
    Callegari, Ernesto
    Tse, Susanna
    Doran, Angela C.
    Goosen, Theunis C.
    Shaik, Naveed
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (01): : 80 - 93
  • [3] MOCRAVIMOD DOES NOT HAVE A CLINICALLY RELEVANT DRUG-DRUG INTERACTION WITH STRONG CYP3A4 INHIBITOR ITRACONAZOLE
    Huntjens, Dymphy
    Oehen, Stephan
    Kueenburg, Elisabeth
    BONE MARROW TRANSPLANTATION, 2024, 59 : 740 - 741
  • [4] The drug-drug interaction of sorafenib mediated by P-glycoprotein and CYP3A4
    Wang, Xianming
    Zhang, Xiang
    Huang, Xinhui
    Li, Yuntong
    Wu, Mengchao
    Liu, Jingfeng
    XENOBIOTICA, 2016, 46 (07) : 651 - 658
  • [5] Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes
    Byeon, Ji-Yeong
    Lee, Yun Jeong
    Kim, Young-Hoon
    Kim, Se-Hyung
    Lee, Choong-Min
    Bae, Jung-Woo
    Jang, Choon-Gon
    Lee, Seok-Yong
    Choi, Chang-Ik
    ARCHIVES OF PHARMACAL RESEARCH, 2018, 41 (05) : 564 - 570
  • [6] Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes
    Ji-Yeong Byeon
    Yun Jeong Lee
    Young-Hoon Kim
    Se-Hyung Kim
    Choong-Min Lee
    Jung-Woo Bae
    Choon-Gon Jang
    Seok-Yong Lee
    Chang-Ik Choi
    Archives of Pharmacal Research, 2018, 41 : 564 - 570
  • [7] Drug-Drug Interactions between Atorvastatin and Dronedarone Mediated by Monomeric CYP3A4
    Denisov, Ilia G.
    Baylon, Javier L.
    Grinkova, Yelena V.
    Tajkhorshid, Emad
    Sligar, Stephen G.
    BIOCHEMISTRY, 2018, 57 (05) : 805 - 816
  • [8] CYP3A4 HUMANIZED MOUSE; A MODEL TO STUDY CYP3A4-MEDIATED DRUG-DRUG INTERACTION POTENTIAL
    Rose, Anne
    Xu, Carrie
    Johnghar, Susan
    Behnia, Kamelia
    DRUG METABOLISM REVIEWS, 2012, 44 : 76 - 77
  • [9] Homotropic and heterotropic cooperativity of CYP3A4 and drug-drug interactions
    Denisov, Ilia G.
    Frank, Daniel
    Grinkova, Yelena V.
    Sligar, Stephen G.
    FASEB JOURNAL, 2008, 22
  • [10] Drug-Drug Interaction between (S)-Rivaroxaban and Orthopedics Treatment Drugs Mainly Undergoing CYP3A4 Metabolism
    Shi, Jian-Sheng
    Guo, Yang
    LATIN AMERICAN JOURNAL OF PHARMACY, 2015, 34 (03): : 613 - 615
12345